PREFILLED SYRINGES MARKET ANALYSIS

Prefilled Syringes Market, by Material (Glass, Plastic/Polymer), by Drug Type (Biologics, Vaccines, Insulin, Anticoagulants, Flush Saline Syringes and Others), by Design (Single-chamber, Dual-chamber, and Multi-chambered), by Product Type (Staked in-needle pre-filled syringes and Needle-free pre-filled syringes), by Usability (Disposable and Reusable), by Manufacturing Method (Captive and Merchant), by End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI162
Pages :401
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Prefilled Syringes Market– Impact of Coronavirus (COVID-19) Pandemic

Coronavirus disease 2019 (COVID-19) is a highly contagious infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to World Health Organization (WHO) as of April 06, 2023, 762,201,169 people are affected worldwide.

For treatment of COVID-19, government with the pharmaceutical companies launched vaccines for the COVID-19. Due to the launches of vaccine, there was increase in demand for prefilled syringes, and this is expected to positively impact the growth of global prefilled syringes market over forecast period. For instance, in July 2022, Novavax, Inc., a biotechnology company that is dedicated to developing and commercializing next-generation vaccines for critical infectious illnesses, signed an agreement with its partner, SK bioscience, a global vaccine and biotechnology company, for the manufacture and supply of an Omicron variant of the Novavax COVID-19 vaccine (NVX-CoV2373), as well as the manufacture of the vaccine in prefilled syringe.